Therapeutic Agents for COVID-19: an Overview
Journal:
Current Drug Therapy
Volume:
16
Page:
22-44
Author(s):
Sreejan Manna, Mainak Mal, Manas Bhowmik and Dipika Mandal*
Autism - A Comprehensive Array of Prominent Signs and Symptoms
Journal:
Current Pharmaceutical Design
Volume:
27
Page:
1418-1433
Author(s):
Muhammad Shahid Nadeem, Bibi Nazia Murtaza*, Maryam A. Al-Ghamdi, Akbar Ali, Mazin A. Zamzami, Jalaluddin A. Khan, Aftab Ahmad, Mujaddad Ur Rehman and Imran Kazmi*
Natural Products, a Potential Therapeutic Modality in Management and Treatment of nCoV-19 Infection: Preclinical and Clinical Based Evidence
Journal:
Current Pharmaceutical Design
Volume:
27
Page:
1153-1169
Author(s):
Ashif Iqubal, Mohammad K. Iqubal, Musheer Ahmed and Syed E. Haque*
Curcumin and its Multi-target Function Against Pain and Inflammation: An Update of Pre-clinical Data
Journal:
Current Drug Targets
Volume:
22
Page:
656-671
Author(s):
Shaikh Jamal Uddin*, Md. Fahim Hasan, Mohasana Afroz, Dipto Kumer Sarker, Razina Rouf, Muhammad Torequl Islam, Jamil A. Shilpi and Mohammad S. Mubarak*
Progress in Detection of Insomnia Sleep Disorder: A Comprehensive Review
Journal:
Current Drug Targets
Volume:
22
Page:
672-684
Author(s):
Md Belal Bin Heyat, Faijan Akhtar, M.A. Ansari, Asif Khan, Fahed Alkahtani, Haroon Khan* and Dakun Lai*
Yoga may Prevent Cytokine Storm in COVID-19
Journal:
Coronaviruses
Volume:
2
Page:
284-288
Author(s):
Surabhi Gautam and Rima Dada*
COVID-19: A Great Mime or a Trigger Event of Autoimmune Manifestations?
Journal:
Current Rheumatology Reviews
Volume:
17
Page:
7-16
Author(s):
Maria Celeste Fatone*
Current Therapeutic Options for the Treatment of Juvenile Idiopathic Arthritis
Journal:
Current Rheumatology Reviews
Volume:
17
Page:
41-57
Author(s):
Ioanna G. Saougou, Theodora E. Markatseli, Paraskevi V. Voulgari and Alexandros A. Drosos*
Atherogenic Index of Plasma in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus: A 10-Year Potential Predictor of Cardiovascular Disease
Journal:
Current Rheumatology Reviews
Volume:
17
Page:
122-130
Author(s):
Nevin Hammam*, Noha Abdel-Wahab and Tamer A Gheita
PCSK9 Inhibitors for the Management of Dyslipidemia in People with Type 2 Diabetes: How Low is Too Low?
Journal:
Current Pharmaceutical Design
Volume:
27
Page:
1008-1014
Author(s):
Ioannis Felekos, Grigoris V. Karamasis and Antonis N. Pavlidis*